Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a
- PMID: 1730477
- PMCID: PMC257650
- DOI: 10.1128/iai.60.2.465-471.1992
Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a
Abstract
The effects of parenteral administration of a killed typhoid vaccine on the intestinal immune response to live orally administered Salmonella typhi Ty21a in human subjects was evaluated. Priming with parenteral vaccination neither enhanced nor suppressed the subsequent specific serum and intestinal immunoglobulin A (IgA) immune responses to a booster course of live oral vaccine. Neither a single oral dose of live vaccine nor a single dose of parenteral vaccine had any measurable booster effect on the observed primary intestinal IgA response to the live oral vaccine. Two booster doses of subcutaneously administered killed typhoid vaccine did result in a significant increase in the specific intestinal IgA antibody in those subjects primed with the oral live vaccine. This response was comparable in magnitude to the primary intestinal response. No evidence of this response could be found in serum IgA, although nonsignificant rises in serum IgG were evident. Previous parenteral priming had no effect on secondary immune responses to a live oral vaccine in humans. Serum immune responses were generally found to be of little value as indicators of local intestinal immunity. This study confirmed that parenteral vaccination was only able to induce an intestinal immune response following priming with live, orally administered organisms and that multiple parenteral booster doses were necessary to induce a measurable effect on intestinal immune responses.
Similar articles
-
Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a as measured using peripheral blood lymphocytes.Vaccine. 1993;11(2):136-9. doi: 10.1016/0264-410x(93)90008-l. Vaccine. 1993. PMID: 8438612 Clinical Trial.
-
Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans.Clin Immunol. 2011 Feb;138(2):187-200. doi: 10.1016/j.clim.2010.11.006. Epub 2010 Dec 10. Clin Immunol. 2011. PMID: 21146460 Free PMC article. Clinical Trial.
-
Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.Vaccine. 2015 Jan 9;33(3):451-8. doi: 10.1016/j.vaccine.2014.11.030. Epub 2014 Nov 26. Vaccine. 2015. PMID: 25433216
-
Vaccination against typhoid fever: present status.Bull World Health Organ. 1994;72(6):957-71. Bull World Health Organ. 1994. PMID: 7867143 Free PMC article. Review.
-
CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S20-3. doi: 10.1086/518135. Clin Infect Dis. 2007. PMID: 17582563 Review.
Cited by
-
Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.Infect Immun. 1994 Feb;62(2):412-20. doi: 10.1128/iai.62.2.412-420.1994. Infect Immun. 1994. PMID: 7507892 Free PMC article.
-
Light emission from a Mudlux transcriptional fusion in Salmonella typhimurium is stimulated by hydrogen peroxide and by interaction with the mouse macrophage cell line J774.2.Infect Immun. 1993 Feb;61(2):640-9. doi: 10.1128/iai.61.2.640-649.1993. Infect Immun. 1993. PMID: 8423094 Free PMC article.
-
Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain.Infect Immun. 1996 Dec;64(12):5219-24. doi: 10.1128/iai.64.12.5219-5224.1996. Infect Immun. 1996. PMID: 8945569 Free PMC article. Clinical Trial.
-
Is there a role for a mucosal influenza vaccine in the elderly?Drugs Aging. 1999 Sep;15(3):169-81. doi: 10.2165/00002512-199915030-00001. Drugs Aging. 1999. PMID: 10503810 Review.
-
Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine.Infect Immun. 1992 May;60(5):2023-9. doi: 10.1128/iai.60.5.2023-2029.1992. Infect Immun. 1992. PMID: 1563793 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous